Advertisement

Topics

EMA launches new EudraVigilance system for adverse reactions

05:04 EDT 30 Jun 2017 | Generics and Biosimilars Initiative

The European Medicines Agency (EMA) announced that it will launch a ‘new and improved version of EudraVigilance’ in November 2017, which will contain enhancements for reporting and analysing suspected adverse reactions.

Original Article: EMA launches new EudraVigilance system for adverse reactions

NEXT ARTICLE

More From BioPortfolio on "EMA launches new EudraVigilance system for adverse reactions"

Advertisement
Quick Search
Advertisement
Advertisement